These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18881070)

  • 1. Quantitative assay of neutralizing antibody content of pools of gamma globulin from different sections of the United States against the viruses of herpes simplex, lymphocytic choriomeningitis and epidemic keratoconjunctivitis.
    HEYL JT; ALLEN HF; CHEEVER FS
    J Immunol; 1948 Sep; 60(1):37-45. PubMed ID: 18881070
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic reactions of human serum gamma globulin in herpes simplex and epidemic keratoconjunctivitis.
    ALLEN HF
    Am J Ophthalmol; 1948 Nov; 31(11):1495. PubMed ID: 18894731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics].
    Turkulov V; Madle-Samardzija N; Ilić A; Vukadinov J; Canak G
    Med Pregl; 1998; 51(9-10):436-40. PubMed ID: 9863335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the protective effect of gamma globulin against herpes simplex infections in mice.
    CHEEVER FS; DAIKOS G
    J Immunol; 1950 Jul; 65(1):135-41. PubMed ID: 15436993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibodies in gamma-globulin preparations (author's transl)].
    Kunz Ch; Hofmann H; Stary A
    Wien Klin Wochenschr; 1977 Mar; 89(6):203-6. PubMed ID: 66804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUBELLA VIRUS: NEUTRALIZING ANTIBODY IN COMMERCIAL GAMMA GLOBULIN.
    SCHIFF GM; SEVER JL; HUEBNER RJ
    Science; 1963 Oct; 142(3588):58-60. PubMed ID: 14057354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aetiology of keratoconjunctivitis in epidemic and non-epidemic periods.
    Jancsó A; Simon M
    Acta Microbiol Acad Sci Hung; 1965; 12(2):123-9. PubMed ID: 4284270
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON PRIMARY HERPETIC KERATOCONJUNCTIVITIS IN CHILDHOOD].
    KAPLINA KP
    Oftalmol Zh; 1964; 19():100-3. PubMed ID: 14176573
    [No Abstract]   [Full Text] [Related]  

  • 9. PASSIVE IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF INHALATION LYMPHOCYTIC CHORIOMENINGITIS IN GUINEA-PIGS.
    BENDA R
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():243-51. PubMed ID: 14184880
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT.
    YOSHINO K; TANIGUCHI S
    Virology; 1965 May; 26():44-53. PubMed ID: 14295231
    [No Abstract]   [Full Text] [Related]  

  • 11. [The epidemic of keratoconjunctivitis of the spring of 1973].
    Mihail S; Chisim T; Niculiu I; Corneliu N; Crăciunescu D; Săvescu D; Bărcănescu E
    Otorinolaringologie; 1974; 19(2):129-32. PubMed ID: 4136459
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of experimental herpes simplex iridocyclitis with human serum gamma-globulin.
    HOWARD JL; ALLEN HF
    AMA Arch Ophthalmol; 1958 Jan; 59(1):68-72. PubMed ID: 13486994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of complement fixing antibodies against Herpes simplex virus (and other neurotropic viruses) in patients with multiple sclerosis].
    Ortona L; Pizzigallo E; Gelfo P
    Minerva Med; 1973 Mar; 64(11):517-24. PubMed ID: 4350584
    [No Abstract]   [Full Text] [Related]  

  • 14. [VIRAL GENESIS AND THERAPY OF EPIDEMIC KERATOCONJUNCTIVITIS].
    VON WOLFFERSDORFF
    Klin Monbl Augenheilkd; 1963 Nov; 143():550-63. PubMed ID: 14097585
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE EFFECT OF NEUTRALIZING ANTIBODIES PASSIVELY TRANSMITTED ON LOCAL DISEASES CAUSED BY A DIFFERENT TYPE OF VIRUS: THE PHENOMENON OF ACCELERATED IMMUNIZATION].
    ROGER F; ROGER A
    C R Hebd Seances Acad Sci; 1964 Dec; 259():4886-8. PubMed ID: 14257441
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of the suppository form of human immunoglobulin preparation with high titers of antibodies to herpes simplex virus types 1 and 2 for the treatment of chronic forms of herpetic disease.
    Lazarenko AA; Alimbarova LM; Mordvintseva EY; Barinsky IF
    Vopr Virusol; 2017; 62(1):36-41. PubMed ID: 29323845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemic keratoconjunctivitis].
    Lazarov E
    Otorinolaringologie; 1974; 19(2):143-54. PubMed ID: 4136357
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.
    Baccari A; Cooney M; Blevins TP; Morrison LA; Larson S; Skoberne M; Belshe RB; Flechtner JB; Long D
    Vaccine; 2016 Jul; 34(33):3901-6. PubMed ID: 27265458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemic kerato-conjunctivitis in Batavia during 1946 to 1947.
    SIE-BOEN-LIAN
    Ophthalmologica; 1948 Aug; 116(2):86-100. PubMed ID: 18879920
    [No Abstract]   [Full Text] [Related]  

  • 20. HERPES SIMPLEX INFECTION IN FEMALE GENITAL TRACT.
    YEN SS; REAGAN JW; ROSENTHAL MS
    Obstet Gynecol; 1965 Apr; 25():479-92. PubMed ID: 14275292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.